Laufey Tryggvadottir
Professor
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
Background and purpose: Organised mammography screening reduces breast cancer mortality by 30–40% in women aged 50–69. Despite limited evidence for women aged 40–49, screening guidelines are trending toward younger ages. Iceland has offered biennial screening to women aged 40–69 since 1987. This study compares screening quality indicators and tumour characteristics between women aged 40–49 and 50–69 from 1990 to 2020. Patient/material and methods: Screening-related data were obtained from the Icelandic Breast Cancer Screening Program, and breast cancer diagnoses and tumour characteristics were sourced from the Icelandic Cancer Registry. Results: In total, 84,677 women aged 40–69 years attended 455,532 organised screening sessions in Iceland over a 30-year period. Women aged 40–49 years demonstrated higher recall rates (4.9% vs. 3.5%) and lower participation rates (60.7% vs. 61.5%), lower breast cancer detection rates (2.1 vs. 6.0/1,000), and lower episode sensitivity (54.8% vs. 70.5%), compared to those aged 50–69 years. Among screen-detected cases, women aged 40–49 years exhibited a higher proportion of tumours larger than 20 mm (29.7% vs. 21.7%), more lymph node positivity (41.2% vs. 28.2%) and higher human epidermal growth factor receptor 2 (HER2) positivity (18.6% vs. 11.8%), compared to those aged 50–69 years. Interpretation: The disparity in breast cancer screening performances between the age groups may reflect unmodifiable factors in younger women. The presence of advanced tumour characteristics among women aged 40–49 years who attended screening indicates the importance of early detection for improving prognosis.
Year:
2025
Two-thirds of all human conceptions are lost, in most cases before clinical detection. The lack of detailed understanding of the causes of pregnancy losses constrains focused counseling for future pregnancies. We have previously shown that a missense variant in synaptonemal complex central element protein 2 ( SYCE2 ), in a key residue for the assembly of the synaptonemal complex backbone, associates with recombination traits. Here we show that it also increases risk of pregnancy loss in a genome-wide association analysis on 114,761 women with reported pregnancy loss. We further show that the variant associates with more random placement of crossovers and lower recombination rate in longer chromosomes but higher in the shorter ones. These results support the hypothesis that some pregnancy losses are due to failures in recombination. They further demonstrate that variants with a substantial effect on the quality of recombination can be maintained in the population.
Year:
2024
Collaborators (12)
Søren Brunak
Professor of Disease Systems Biology, Research Director
Københavns Universitet
Karina Banasik
Associate Professor
Technical University of Denmark
Sisse Rye Ostrowski
Københavns Universitet
David Westergaard
Associate Professor
Technical University of Denmark
H S Nielsen
Professor
Copenhagen University Hospital
Kari Stefansson
Professor
University of Iceland
Christian Erikstrup
Chair Professor
Aarhus University
Mette Nyegaard
Head of Department
Aalborg University
Ásgeir Haraldsson
-
Thomas Folkmann Hansen
Professor
Technical University of Denmark
Ole Birger Pedersen
Professor
Zealand University Hospital
Eva Hoffmann
Professor
Københavns Universitet
Make your next move.
Prepare your application
Review drafts before you send them.